Abeona Therapeutics ABEOW 深 沪
等待开盘 05-19 09:30:00 美东时间
0.0698
0.000
0.00%
华盛通- 最 高--
- 今 开--
- 成交量 0股
- 最 低 --
- 昨 收 0.0698
- 总市值 2.11亿
- 52周最高 4.00
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 0.021
- 委 比 0.00%
- 总股本 30.28亿
- 历史最高 17.56
- 量 比 0
- 振 幅 0.00%
- 历史最低 0.021
- 每 手 1
- 风险率 0.00%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript
On Wednesday, Abeona Therapeutics (NASDAQ:ABEO) discussed first-quarter financi...
05-13 21:51
Abeona Therapeutics posts smaller-than-expected Q1 loss per share
Abeona Therapeutics posts smaller-than-expected Q1 loss per share Overview US biopharma's Q1 net product revenue rose quarter-over-quarter as ZEVASKYN adoption increased Q1 loss per share beat analyst expectations Co has $168.3M in cash, cash equivalents and short-term investments as of March 31, 20
05-13 19:40
Abeona Therapeutics Q1 EPS $(0.30) Beats $(0.35) Estimate, Sales $8.720M Beat $4.572M Estimate
Abeona Therapeutics (NASDAQ:ABEO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.35) by 14.29 percent. This is a 25 percent decrease over losses of $(0.24) per share from
05-13 19:35
Abeona Q1 FY26 net loss widens to $17.1 million; revenue rises to $8.7 million
Abeona Q1 FY26 net loss widens to $17.1 million; revenue rises to $8.7 million Abeona Therapeutics posted Q1 2026 revenue of USD 8.7 million, up USD 6.3 million from Q4 2025, as net loss widened to USD 17.1 million, or USD 0.30 per share. Selling, general and administrative expense climbed to USD 19
05-13 19:31
Earnings Scheduled For May 13, 2026
Companies Reporting Before The Bell • Similarweb (NYSE:SMWB) is estimated to re...
05-13 19:11
Abeona Therapeutics Activates Children's Hospital Of Philadelphia As Sixth Qualified Treatment Center To Treat ZEVASKYN Gene-Modified Cellular Sheets
Abeona Therapeutics Inc. (NASDAQ:ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced activation of the Children's Hospital of
05-11 20:34
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York
Abeona Therapeutics Inc. has activated the NewYork-Presbyterian/Columbia University Irving Medical Center as its fifth Qualified Treatment Center (QTC) for ZEVASKYN, a gene-modified cellular sheet therapy for recessive dystrophic epidermolysis bullosa (RDEB). This expansion enhances patient access in the Northeast, leveraging the institution’s expertise in genetic medicines and skin disorders. ZEVASKYN is the first autologous cell sheet-based gen...
04-02 12:30
Abeona CEO Vishwas Seshadri disposes of ABEO shares worth $0.13 million
Abeona CEO Vishwas Seshadri disposes of ABEO shares worth $0.13 million Abeona Therapeutics CEO Vishwas Seshadri sold 29,985 common shares on March 31, 2026. Sale priced at $4.38 per share on a weighted-average basis. Holdings fell to 1,430,423 shares following transaction. Disclaimer: This news bri
04-01 09:26
Abeona Therapeutics Tightens Shareholder Meeting and Governance Rules
Abeona Therapeutics ( ($ABEO) ) has provided an announcement. On March 16, 2026...
03-21 05:07
Abeona Therapeutics Balances Big Windfall With Slow Ramp
Abeona Therapeutics Inc (($ABEO)) has held its Q4 earnings call. Read on for th...
03-18 08:15
